https://doi.org/10.1038/nm.3562
F
Francesca Cottini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
149
Papers
2.0K
Citations
19
h-index
25
i10-index
Francesca Cottini is an academic researcher from Harvard University. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Peptidase Inhibition and Analysis. The author has an h-index of 19, co-authored 127 publications.
ORCID: 0000-0001-8676-7840Papers by this author
worksRescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers
2014 · Nature Medicine · 308 citations
Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma
2015 · Blood Cancer Journal · 63 citations
https://doi.org/10.1038/bcj.2015.38
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma
2014 · Leukemia · 33 citations
https://doi.org/10.1038/leu.2014.300
[Hemorrhoidectomy with ropivacaine (Naropin) local anesthesia. Preliminary experience].
2000 · PubMed · 3 citations
Development of Novel CREB1-PROTACs for Enhanced Targeting of CREB1 in Multiple Myeloma
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)03755-3
Regulation of stress tolerance by CREB1 sustains multiple myeloma cell survival
2026 · Cell Death and Disease · 0 citations
https://doi.org/10.1038/s41419-025-08246-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat